Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 4
2005 4
2006 1
2007 2
2009 3
2010 2
2011 2
2012 3
2013 3
2014 1
2015 3
2019 1
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

32 results
Results by year
Filters applied: . Clear all
Page 1
Bridging oncology and immunology: expanding horizons with innovative peptide vaccines and peptidomimetics.
Kaumaya PT. Kaumaya PT. Immunotherapy. 2013 Nov;5(11):1159-63. doi: 10.2217/imt.13.128. Immunotherapy. 2013. PMID: 24188668 Review. No abstract available.
Immunogenicity and antitumor efficacy of a novel human PD-1 B-cell vaccine (PD1-Vaxx) and combination immunotherapy with dual trastuzumab/pertuzumab-like HER-2 B-cell epitope vaccines (B-Vaxx) in a syngeneic mouse model.
Kaumaya PTP, Guo L, Overholser J, Penichet ML, Bekaii-Saab T. Kaumaya PTP, et al. Oncoimmunology. 2020 Oct 1;9(1):1818437. doi: 10.1080/2162402X.2020.1818437. Oncoimmunology. 2020. PMID: 33117602 Free PMC article.
Phase I Immunotherapy Trial with Two Chimeric HER-2 B-Cell Peptide Vaccines Emulsified in Montanide ISA 720VG and Nor-MDP Adjuvant in Patients with Advanced Solid Tumors.
Bekaii-Saab T, Wesolowski R, Ahn DH, Wu C, Mortazavi A, Lustberg M, Ramaswamy B, Fowler J, Wei L, Overholser J, Kaumaya PTP. Bekaii-Saab T, et al. Among authors: kaumaya ptp. Clin Cancer Res. 2019 Jun 15;25(12):3495-3507. doi: 10.1158/1078-0432.CCR-18-3997. Epub 2019 Feb 25. Clin Cancer Res. 2019. PMID: 30804020 Free PMC article. Clinical Trial.
Synthetic peptides as cancer vaccines.
Sundaram R, Dakappagari NK, Kaumaya PT. Sundaram R, et al. Biopolymers. 2002;66(3):200-16. doi: 10.1002/bip.10258. Biopolymers. 2002. PMID: 12385038 Review.
Cancer immunotherapy: present status, future perspective, and a new paradigm of peptide immunotherapeutics.
Miller MJ, Foy KC, Kaumaya PT. Miller MJ, et al. Discov Med. 2013 Mar;15(82):166-76. Discov Med. 2013. PMID: 23545045 Free article. Review.
Advances in HTLV-1 peptide vaccines and therapeutics.
Lynch MP, Kaumaya PT. Lynch MP, et al. Curr Protein Pept Sci. 2006 Apr;7(2):137-45. doi: 10.2174/138920306776359803. Curr Protein Pept Sci. 2006. PMID: 16611139 Review.
A paradigm shift: Cancer therapy with peptide-based B-cell epitopes and peptide immunotherapeutics targeting multiple solid tumor types: Emerging concepts and validation of combination immunotherapy.
Kaumaya PT. Kaumaya PT. Hum Vaccin Immunother. 2015;11(6):1368-86. doi: 10.1080/21645515.2015.1026495. Hum Vaccin Immunother. 2015. PMID: 25874884 Free PMC article. Review.
Peptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy.
Kaumaya PT, Foy KC. Kaumaya PT, et al. Future Oncol. 2012 Aug;8(8):961-87. doi: 10.2217/fon.12.95. Future Oncol. 2012. PMID: 22894670 Free PMC article. Review.
Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade.
Allen SD, Rawale SV, Whitacre CC, Kaumaya PT. Allen SD, et al. J Pept Res. 2005 Jun;65(6):591-604. doi: 10.1111/j.1399-3011.2005.00256.x. J Pept Res. 2005. PMID: 15885118 Review.
Immunization with synthetic VEGF peptides in ovarian cancer.
Wang B, Kaumaya PT, Cohn DE. Wang B, et al. Gynecol Oncol. 2010 Dec;119(3):564-70. doi: 10.1016/j.ygyno.2010.07.037. Epub 2010 Sep 6. Gynecol Oncol. 2010. PMID: 20822802 Free PMC article.
32 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback